Mon Sep 23 22:10:00 UTC 2024: ## Investors in Lifecore Biomedical Can Join Class Action Lawsuit

**New York, NY, September 23, 2024** – The Rosen Law Firm, a leading investor rights law firm, is reminding investors who purchased securities of Lifecore Biomedical, Inc. (NASDAQ: LFCR) between October 7, 2020, and March 19, 2024, of an upcoming deadline to join a class action lawsuit. The deadline to be considered as lead plaintiff is September 27, 2024.

The lawsuit alleges that Lifecore made misleading statements about its financial reporting and internal controls, which ultimately led to the company issuing inaccurate financial statements that needed to be restated. These inaccuracies impacted the company’s ability to file reports with the Securities and Exchange Commission and ultimately resulted in a decline in the value of Lifecore securities.

Investors who purchased Lifecore securities during the class period may be entitled to compensation without paying any out-of-pocket fees or costs. They can join the class action by visiting the Rosen Law Firm website or contacting Phillip Kim, Esq. toll-free at 866-767-3653.

The Rosen Law Firm encourages investors to choose qualified counsel with a strong track record of success in securities class action lawsuits. The firm boasts a long history of recovering millions of dollars for investors. In 2019 alone, they secured over $438 million for investors.

**Note:** The class action lawsuit has not yet been certified. Individuals are not represented by counsel unless they retain one, and they can choose their own counsel. They can also choose to remain an absent class member and take no action at this time. Participation in any potential recovery is not dependent on serving as lead plaintiff.

Read More